Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Prime Medicine Inc (NQ: PRME )

9.540 +0.040 (+0.42%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 227,460
Open 9.580
Bid (Size) 9.540 (3)
Ask (Size) 10.39 (1)
Prev. Close 9.500
Today's Range 9.355 - 9.715
52wk Range 9.250 - 21.73
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 386 stocks made new 52-week lows. 
Via Benzinga
2 Cathie Wood Stocks That Could Be Hidden Gems
These two biotech stocks could deliver life-altering returns for long-term investors. 
Via The Motley Fool

Performance

YTD
-45.61%
-45.61%
1 Month
-27.67%
-27.67%
3 Month
-34.88%
-34.88%
6 Month
-22.44%
-22.44%
1 Year
-37.93%
-37.93%

More News

Read More
Prime Medicine to Present at Upcoming Investor Conferences
From Prime Medicine, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
Via Benzinga
Prime Medicine to Present at Upcoming Investor Conferences
From Prime Medicine, Inc.
Via GlobeNewswire
Prime Medicine Reports Second Quarter 2023 Financial Results and Provides Business Updates
From Prime Medicine, Inc.
Via GlobeNewswire
Prime Medicine and Cimeio Therapeutics Announce Research Collaboration to Develop Prime Edited Shielded-Cell & Immunotherapy Pairs™ for Genetic Diseases, Acute Myeloid Leukemia and Myelodysplastic Syndrome
From Prime Medicine, Inc.
Via GlobeNewswire
Cathie Wood Goes Bargain-Hunting: 3 Stocks She Just Bought
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
Via Benzinga
Prime Medicine to Present at Investor Conferences in June
From Prime Medicine, Inc.
Via GlobeNewswire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Via The Motley Fool
Prime Medicine to Present at Virtual Investor Conferences in May
From Prime Medicine, Inc.
Via GlobeNewswire
Prime Medicine to Present New Preclinical Data Highlighting Broad Potential of Prime Editing Technology at ASGCT 26th Annual Meeting
From Prime Medicine, Inc.
Via GlobeNewswire
Prime Medicine Reports First Quarter 2023 Financial Results and Provides Business Updates
From Prime Medicine, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2023
Via Benzinga
Prime Medicine to Present at Guggenheim Healthcare Talks – Genomic Medicines and Rare Disease Days
From Prime Medicine, Inc.
Via GlobeNewswire
Prime Medicine Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From Prime Medicine, Inc.
Via GlobeNewswire
Prime Medicine to Present at Cowen 43rd Annual Health Care Conference
From Prime Medicine, Inc.
Via GlobeNewswire
10 Short Squeeze Candidates: Getty Images, Genius Brands, MicroStrategy And More
Via Benzinga
Prime Medicine Announces Recent Progress and Highlights 2023 Strategic Priorities
From Prime Medicine, Inc.
Via GlobeNewswire
Prime Medicine to Present at 41st Annual J.P. Morgan Healthcare Conference
From Prime Medicine, Inc.
Via GlobeNewswire
Why Iovance Biotherapeutics Shares Are Trading Higher By Around 19%? Here Are 40 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
VF Corp, Verve Therapeutics And Some Other Big Stocks Moving Lower On Monday
Via Benzinga
Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
CinCor Pharma, Anavex Life Sciences And Some Other Big Stocks Moving Lower On Monday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.